GeneDx Holdings Corp.
WGS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,103 | $2,638 | $2,493 | $2,075 |
| - Cash | $96 | $74 | $100 | $85 |
| + Debt | $113 | $114 | $115 | $116 |
| Enterprise Value | $3,120 | $2,678 | $2,508 | $2,106 |
| Revenue | $117 | $103 | $87 | $96 |
| % Growth | 13.7% | 17.9% | -8.9% | – |
| Gross Profit | $85 | $71 | $58 | $66 |
| % Margin | 72.4% | 69% | 67.1% | 69.2% |
| EBITDA | -$0 | $18 | $0 | $14 |
| % Margin | -0.3% | 17.1% | 0.3% | 15% |
| Net Income | -$8 | $11 | -$7 | $5 |
| % Margin | -6.5% | 10.5% | -7.5% | 5.7% |
| EPS Diluted | -0.27 | 0.36 | -0.23 | 0.2 |
| % Growth | -175% | 256.5% | -215% | – |
| Operating Cash Flow | $16 | $10 | $10 | -$3 |
| Capital Expenditures | -$6 | -$2 | -$6 | -$3 |
| Free Cash Flow | $10 | $8 | $4 | -$6 |